The genomics industry has formed a new alliance to strengthen collaboration, coordinate on key issues and realise opportunities for all Australians to benefit from precision healthcare.
The Industry Genomics Network Alliance (InGeNA) was launched today with 13 founding member companies in healthcare and life sciences who will collaborate on programs to embed genomics across Australian healthcare.
The contribution of the founding companies, from pathology, technology and biopharma sectors, are matched by funding of $300,000 from MTPConnect Australia’s Industry Growth Centre for the medical technology and pharmaceutical sector (MTP), an Australian Government initiative supported by the Department of Industry, Science, Energy and Resources.
InGeNA will be led by the Institute to undertake a targeted program of work to address a range of genomics opportunities and challenges from screening and testing through to treatment.
Projects include white papers, consultation and policy positions on key areas including access and equity, genetic screening, dynamic consent, workforce planning, and adoption of new drugs and novel medical technologies.
TrakGene is proud to be one of the 13 collaborating partners and look forward to working with InGeNA and other collaborating partners on various projects in our collective pursuit to overcome challenges and realise a range of opportunities in genomics.
English (UK) 
Suomi 
Français 
Deutsch 
हिन्दी 
Italiano 
Bahasa Melayu 
Español 
සිංහල